Moolec Received NASDAQ Bid Price Letter
Moolec Science SA (NASDAQ:MLEC), a food ingredient company, received a Nasdaq Bid Price Letter due to its closing bid price falling below $1.00 for 30 consecutive business days. This violates Nasdaq Listing Rule 5550(a)(2). The company has until March 10, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of ten consecutive business days. If unsuccessful, Moolec may be eligible for an additional 180-day compliance period, provided it meets other Nasdaq Capital Market listing requirements. Failure to comply could result in delisting. Moolec is committed to resolving the deficiency and maintaining its Nasdaq listing.
Moolec Science SA (NASDAQ:MLEC), un'azienda di ingredienti alimentari, ha ricevuto una Letter of Nasdaq Bid Price a causa del suo prezzo di chiusura che è sceso sotto $1,00 per 30 giorni lavorativi consecutivi. Ciò viola la Regola di Quotazione Nasdaq 5550(a)(2). L'azienda ha tempo fino al 10 marzo 2025 per ripristinare la conformità mantenendo un prezzo di chiusura di almeno $1,00 per un minimo di dieci giorni lavorativi consecutivi. In caso di insuccesso, Moolec potrebbe essere idonea a un ulteriore periodo di conformità di 180 giorni, a condizione di soddisfare altri requisiti di quotazione del Nasdaq Capital Market. Il mancato rispetto potrebbe comportare la delisting. Moolec è impegnata a risolvere la carenza e a mantenere la sua quotazione su Nasdaq.
Moolec Science SA (NASDAQ:MLEC), una empresa de ingredientes alimentarios, recibió una carta de oferta de Nasdaq debido a que su precio de cierre ha caído por debajo de $1.00 durante 30 días hábiles consecutivos. Esto viola la Regla de Listado 5550(a)(2) de Nasdaq. La empresa tiene hasta el 10 de marzo de 2025 para recuperar la conformidad manteniendo un precio de cierre de al menos $1.00 durante un mínimo de diez días hábiles consecutivos. Si no tiene éxito, Moolec puede ser elegible para un período adicional de 180 días de cumplimiento, siempre que cumpla con otros requisitos de listado del Nasdaq Capital Market. El incumplimiento podría resultar en la deslistación. Moolec está comprometida a resolver la deficiencia y a mantener su listado en Nasdaq.
Moolec Science SA (NASDAQ:MLEC)는 식품 재료 회사로, 30일 연속 거래일 동안 종가가 $1.00 이하로 떨어져 Nasdaq Bid Price Letter를 받았습니다. 이는 Nasdaq 상장 규칙 5550(a)(2)를 위반하는 것입니다. 회사는 2025년 3월 10일까지 최소 10일 연속으로 종가가 $1.00 이상임을 유지하여 규정을 회복해야 합니다. 실패할 경우, Moolec는 Nasdaq Capital Market의 다른 상장 요건을 충족하는 경우 180일의 추가 규정 준수 기간을 받을 수 있습니다. 규정 미준수 시 상장 폐지가 될 수 있습니다. Moolec은 이 문제를 해결하고 Nasdaq 상장을 유지하기 위해 노력하고 있습니다.
Moolec Science SA (NASDAQ:MLEC), une entreprise de composants alimentaires, a reçu une lettre de prix d'offre de Nasdaq en raison de la chute de son prix de clôture en dessous de 1,00 $ pendant 30 jours ouvrables consécutifs. Cela viole la règle de cotation Nasdaq 5550(a)(2). L'entreprise a jusqu'au 10 mars 2025 pour retrouver la conformité en maintenant un prix de clôture d'au moins 1,00 $ pendant un minimum de dix jours ouvrables consécutifs. Si elle échoue, Moolec peut être éligible à une période supplémentaire de conformité de 180 jours, à condition de remplir d'autres exigences de cotation sur le marché des capitaux de Nasdaq. Le non-respect pourrait entraîner la radiation. Moolec s'engage à résoudre cette insuffisance et à maintenir son inscription sur Nasdaq.
Moolec Science SA (NASDAQ:MLEC), ein Unternehmen für Lebensmittelzutaten, erhielt einen Nasdaq Bid Price Brief, da sein Schlusskurs 30 aufeinanderfolgende Geschäftstage unter $1,00 fiel. Dies verstößt gegen die Nasdaq Listungsregel 5550(a)(2). Das Unternehmen hat bis zum 10. März 2025 Zeit, die Konformität wiederherzustellen, indem es einen Schlusskurs von mindestens $1,00 für mindestens zehn aufeinanderfolgende Geschäftstage aufrechterhält. Sollte dies nicht gelingen, kann Moolec für einen weiteren Zeitraum von 180 Tagen konformitätsfähig sein, vorausgesetzt, es erfüllt auch andere Anforderungen für die Listung im Nasdaq Capital Market. Ein Nichteinhalten könnte zur Delistung führen. Moolec ist entschlossen, die Mängel zu beheben und seine Nasdaq-Listung aufrechtzuerhalten.
- None.
- Stock price has fallen below $1.00 for 30 consecutive business days
- Risk of potential delisting from Nasdaq if compliance is not regained
- Company faces challenges in maintaining Nasdaq listing requirements
The NASDAQ bid price notification for Moolec Science (NASDAQ:MLEC) is a concerning development for investors. The company's stock trading below $1 for an extended period indicates weak market sentiment and potential liquidity issues. This situation puts MLEC at risk of delisting, which could severely impact its ability to raise capital and maintain investor confidence.
While the 180-day compliance period provides a grace period, the company faces significant challenges. To regain compliance, MLEC needs to demonstrate substantial business improvements or consider corporate actions like a reverse stock split. However, such moves often signal desperation and may not address underlying issues.
Investors should closely monitor MLEC's financial health, upcoming catalysts and any strategic initiatives to boost shareholder value. The risk of delisting and potential dilution from capital-raising efforts make this stock a high-risk investment at present.
The NASDAQ bid price notification for Moolec Science reflects broader challenges in the food tech sector. Many innovative companies in this space are struggling to maintain investor interest amid economic uncertainties and a shift towards value investing.
MLEC's situation isn't unique, but it's a red flag for the entire alternative protein industry. Investors are increasingly scrutinizing the path to profitability and scalability of these technologies. This trend could lead to a market consolidation, with only the strongest players surviving.
For MLEC to regain compliance, they'll need to demonstrate clear value proposition and progress in commercializing their science-based food ingredients. Partnerships with major food manufacturers or significant breakthroughs in their technology could help restore investor confidence and drive the stock price up.
LUXEMBOURG / ACCESSWIRE / September 13, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company", "Moolec"), a science-based food ingredient company, announced today that it received a letter (the "Nasdaq Bid Price Letter") from Nasdaq notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company's ordinary shares has been below the minimum
The Nasdaq Bid Price Letter has no immediate effect on the listing of the Company's common stock, and its common stock will continue to trade on The Nasdaq Capital Market under the symbol "MLEC".
Under Rule 5810(c)(3)(A), the Company will be provided a compliance period of 180 calendar days, until March 10, 2025, to regain compliance. If at any time during this 180-day period the closing bid price of the Company's securities is at least
In the event the Company does not regain compliance in the first compliance period, it may be eligible to apply for an additional 180 calendar days to regain compliance. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement. The Company will also need to provide written notice of its intention to cure the deficiency during the second compliance period. However, if it appears to the NASDAQ staff that the Company will neither be able nor otherwise eligible to cure the deficiency, it may be subject to delisting by NASDAQ. The Company is committed to regaining compliance.
The Company intends to actively monitor the closing bid price for its ordinary shares and will consider available options to resolve the deficiency and regain compliance with Rule 5550(a)(2).
Contact Information
Press & Media
comms@moolecscience.com
Investor Relations
ir@moolecscience.com
Related Files
Moolec Received NASDAQ Bid Price Letter - 2024.09.13
SOURCE: Moolec Science
View the original press release on newswire.com.
FAQ
What is the deadline for Moolec Science (MLEC) to regain compliance with Nasdaq's minimum bid price requirement?
How can Moolec Science (MLEC) regain compliance with Nasdaq's bid price rule?
What happens if Moolec Science (MLEC) fails to meet Nasdaq's bid price requirement by March 10, 2025?
Is Moolec Science (MLEC) at immediate risk of being delisted from Nasdaq?
